the Press service of Rospotrebnadzor issued a statement, which refers to the development of specialists of the Central research Institute Central research Institute of epidemiology of high-precision test for the detection COVID-2019.
“the Test has successfully passed clinical trials and on March 25, 2024 registered for use in the Russian Federation…… It allows to identify in one study not only SARS-CoV-2, but to differentiate it from other SARS-Cov-related viruses and MERS-Cov”, – stated in the message.
